Key Takeaways
- • South Korean venture capital funding collapsed 72% year-over-year in H1 2023, with total investment declining to 2.82 trillion won ($2.2 billion) as global economic uncertainty and monetary tightening prompted investor retreat into selective deal-making.
- • Deal volume dropped from 1,177 to 547 cases in the first half of 2023, while late-stage venture funding fell 76% with mega-rounds (10 billion won+) plummeting 70% to just 74 deals, representing only 13% of total VC investment.
- • Seed and Series A funding cases declined 52% year-over-year to 443 total deals, with average investment per deal falling to 2.5 billion won from 2.9 billion won as venture capitalists adopted a "wait-and-see mode" targeting entrepreneurs with proven technology and near-term profitability.
- • The Korean VC market demonstrated structural recovery trajectory through 2024-2025, with full-year 2024 venture investment reaching 11.9 trillion won and 2023 showing a 35% increase from pre-COVID peaks despite the H1 2023 contraction, signaling anticipated market stabilization in H2 2023 onward.
- • Growing expectations for a "third venture boom" in 2026 reflect anticipated capital influx into the market, though recovery patterns show clear bifurcation between profitable, manufacturing-focused companies receiving accelerated funding versus platform and biotech startups facing prolonged capital constraints.
Summary
South Korea's venture capital market experienced severe contraction in the first half of 2023, with funding declining 72% year-over-year to 2.82 trillion won ($2.2 billion) amid persistent global economic headwinds and monetary policy tightening. The funding drought extended beyond deal value to transaction volume, with completed deals falling from 1,177 cases to 547 over the same period, according to data from The VC, a Korea-based startup and venture capital tracker.
The funding compression disproportionately affected growth-stage and late-stage startups. Venture-funded companies experienced the most severe capital constraints, with late-stage funding declining 76% in the first half of 2023. Notably, mega-rounds of 10 billion won or greater—historically representing significant venture commitments—collapsed 70% to just 74 deals, accounting for only 13% of total VC investment. Early-stage funding also contracted, with seed and Series A cases declining 52% year-over-year to 443 total transactions, while average investment per deal fell to 2.5 billion won from 2.9 billion won.
Market participants attributed the funding freeze to broader investor conservatism driven by global economic uncertainty. Most venture capitalists shifted into "wait-and-see mode," prioritizing entrepreneurs demonstrating proven technology and clearer paths to profitability over high-growth, pre-revenue business models. Platform and biotech startups bore particularly heavy losses, while manufacturing and content companies with established business models benefited from selective capital deployment. According to LB Investment Inc. managing director Park Ki-ho, anticipated recovery was expected in Q3 2023 when capital from venture funds formed between 2021-2022 would begin deploying into deals.
The market demonstrated resilience in subsequent periods, with 2023 full-year VC investment reaching approximately $8.4 billion (a 35% increase from pre-COVID peaks) and 2024 venture investment totaling 11.9 trillion won. Current market expectations suggest growing anticipation for a "third venture boom" in 2026, driven by anticipated capital influx into the Korean venture ecosystem, though the recovery pattern reflects clear selectivity favoring companies with demonstrated profitability over speculative technology plays.
The funding compression disproportionately affected growth-stage and late-stage startups. Venture-funded companies experienced the most severe capital constraints, with late-stage funding declining 76% in the first half of 2023. Notably, mega-rounds of 10 billion won or greater—historically representing significant venture commitments—collapsed 70% to just 74 deals, accounting for only 13% of total VC investment. Early-stage funding also contracted, with seed and Series A cases declining 52% year-over-year to 443 total transactions, while average investment per deal fell to 2.5 billion won from 2.9 billion won.
Market participants attributed the funding freeze to broader investor conservatism driven by global economic uncertainty. Most venture capitalists shifted into "wait-and-see mode," prioritizing entrepreneurs demonstrating proven technology and clearer paths to profitability over high-growth, pre-revenue business models. Platform and biotech startups bore particularly heavy losses, while manufacturing and content companies with established business models benefited from selective capital deployment. According to LB Investment Inc. managing director Park Ki-ho, anticipated recovery was expected in Q3 2023 when capital from venture funds formed between 2021-2022 would begin deploying into deals.
The market demonstrated resilience in subsequent periods, with 2023 full-year VC investment reaching approximately $8.4 billion (a 35% increase from pre-COVID peaks) and 2024 venture investment totaling 11.9 trillion won. Current market expectations suggest growing anticipation for a "third venture boom" in 2026, driven by anticipated capital influx into the Korean venture ecosystem, though the recovery pattern reflects clear selectivity favoring companies with demonstrated profitability over speculative technology plays.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.